BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 94 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -98.6% | 304 | -97.2% | 0.00% | – |
| Q2 2023 | $73 | -64.0% | 10,951 | +0.6% | 0.00% | – |
| Q1 2023 | $203 | -18.5% | 10,885 | -5.9% | 0.00% | – |
| Q4 2022 | $249 | -99.8% | 11,571 | -0.1% | 0.00% | – |
| Q3 2022 | $137,000 | -9.9% | 11,582 | +0.5% | 0.00% | – |
| Q2 2022 | $152,000 | -36.9% | 11,525 | -0.2% | 0.00% | – |
| Q1 2022 | $241,000 | +2.6% | 11,549 | -0.2% | 0.00% | – |
| Q4 2021 | $235,000 | -33.0% | 11,574 | +0.2% | 0.00% | – |
| Q3 2021 | $351,000 | -21.1% | 11,551 | -24.6% | 0.00% | – |
| Q2 2021 | $445,000 | -53.3% | 15,310 | -30.6% | 0.00% | -100.0% |
| Q1 2021 | $953,000 | +73.3% | 22,070 | +85.5% | 0.00% | 0.0% |
| Q4 2020 | $550,000 | +30.6% | 11,900 | +22.7% | 0.00% | 0.0% |
| Q3 2020 | $421,000 | -18.1% | 9,700 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $514,000 | +264.5% | 9,700 | +54.0% | 0.00% | – |
| Q1 2020 | $141,000 | +5.2% | 6,300 | -31.5% | 0.00% | – |
| Q4 2019 | $134,000 | +106.2% | 9,200 | 0.0% | 0.00% | – |
| Q3 2019 | $65,000 | -35.6% | 9,200 | 0.0% | 0.00% | – |
| Q2 2019 | $101,000 | – | 9,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |